Here are the 424B prospectus supplements from Lantronix Inc (LTRX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow LTRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LTRX filings page.
Lantronix, Inc. is offering 4,166,667 shares of its common stock pursuant to this prospectus supplement, with a public offering price of $7.20 per share and expected delivery on or about June 1, 2026. The offering permits the underwriters a 30-day option to purchase up to 625,000 additional shares at the public offering price less the underwriting discount. Net proceeds to the company are estimated at approximately $28.0 million (or approximately $32.3 million if the option is exercised in full), before offering expenses.
Pro forma shares outstanding after the offering are stated as 43,983,597 (or 44,608,597 if the option is fully exercised), based on 39,816,930 shares outstanding as of March 31, 2026. The prospectus supplement discloses dilution math: historical net tangible book value was $1.03 per share as of March 31, 2026, and as-adjusted net tangible book value would be $1.57 per share after this offering, producing an immediate dilution of $5.63 per share to new investors.
Lantronix, Inc. has priced a prospectus supplement to sell up to $30,000,000 of its common stock in an at-the-market offering pursuant to a Sales Agreement with Needham & Company, LLC and Canaccord Genuity LLC dated May 8, 2026. Sales may occur from time to time through the Sales Agents, who will receive a 3% commission on gross proceeds. The offering example assumes the May 7, 2026 closing price of $5.83 per share and estimates as-adjusted net tangible book value of $1.55 per share after the illustrated $30.0 million raise. Proceeds are intended for working capital and general corporate purposes; timing and amounts sold will depend on market conditions.